Silva Markovic-Plese, MD, PhD
Professor
Contact Information
Professor
Education
Medical School
MD, University of Zagreb Medical School, Croatia
PhD, University of Zagreb, Croatia
Residency
Yale University School of Medicine
Harvard University Medical School
Publications
- Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: An open-label two-arm trial
- IL-11 induces Th17 cell responses in patients with early relapsing-remitting multiple sclerosis
- Immunomodulatory therapies for relapsing-remitting multiple sclerosis: Monoclonal antibodies, currently approved and in testing
- Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing-remitting multiple sclerosis over 24weeks of therapy with subcutaneous interferon beta-1a three times weekly
- The role of fractalkine (CX3CL1) in regulation of CD4+ cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis
- IL-11 in multiple sclerosis
- Dermatomyositis as a presentation of neuromyelitis optica spectrum disorder
- The role of endogenous IFN-β in the regulation of Th17 responses in patients with relapsing-remitting multiple sclerosis
- Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: A 24-week, controlled pilot study
- Differential reconstitution of T cell subsets following immunodepleting treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with relapsing-remitting multiple sclerosis
- Diffusion tensor imaging based network analysis detects alterations of neuroconnectivity in patients with clinically early relapsing-remitting multiple sclerosis
- Simvastatin inhibits secretion of Th17-polarizing cytokines and antigen presentation by DCs in patients with relapsing remitting multiple sclerosis
- Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate
- Pathogenic features of CD4+CD28- T cells in immune disorders
- CX3CR1 drives cytotoxic CD4+CD28- T cells into the brain of multiple sclerosis patients
- Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosis
- Protein changes in CSF of HIV-infected patients: Evidence for loss of neuroprotection
- B cells as a therapeutic target for IFN-β in relapsing-remitting multiple sclerosis
- A role of IL-1R1 signaling in the differentiation of Th17 cells and the development of autoimmune diseases
- T cell LFA-1 engagement induces HuR-dependent cytokine mRNA stabilization through a Vav-1, Rac1/2, p38MAPK and MKK3 signaling cascade
Board Certification
American Board of Psychiatry and Neurology
Hospital Appointment
Thomas Jefferson University Hospitals